Sign in

CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
operating
EIN
112622630
Phone
408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.17 ($15,850)
  2. 4 Open-market buy Director bought 8,000 shares at $2.98 ($23,840)
  3. 4 Open-market buy Chief Executive Officer bought 8,000 shares at $2.72 ($21,760)
  4. 4 Open-market buy President, COO, & CFO bought 5,500 shares at $2.84 ($15,620)
  5. 4 Open-market buy Chief Executive Officer bought 7,000 shares at $2.78 ($19,460)
  6. 4 Open-market buy Director bought 5,000 shares at $2.76 ($13,800)
  7. 4 Open-market buy Director bought 49,036 shares at $2.69 ($131,907)
  8. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $2.75 ($8,250)
  9. 4 Open-market buy Director bought 10,000 shares at $2.73 ($27,300)
  10. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.76 ($13,800)
  11. 10-Q Report Quarterly Report
  12. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.47 ($17,350)
  13. 4 Shares withheld for taxes Director gave up 5,428 shares (to pay taxes)
  14. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.44 ($17,200)
  15. 4 Open-market buy Chief Executive Officer bought 3,188 shares at $3.37 ($10,744)
  16. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.73 ($11,190)
  17. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.46 ($17,300)
  18. 4 Open-market buy Director bought 12,000 shares at $3.47 ($41,640)
  19. 4 Open-market buy Director bought 2,797 shares at $3.28 ($9,174)
  20. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.04 ($15,200)

Page 1 of 50 · 983 filings